tiprankstipranks
Trending News
More News >
Circassia Pharmaceuticals PLC (GB:NIOX)
LSE:NIOX
UK Market

Circassia Pharmaceuticals (NIOX) Ratios

Compare
12 Followers

Circassia Pharmaceuticals Ratios

GB:NIOX's free cash flow for Q2 2024 was £0.72. For the 2024 fiscal year, GB:NIOX's free cash flow was decreased by £ and operating cash flow was £0.20. See a summary of the company’s cash flow.
Ratios
TTM
Dec 23Dec 22Dec 21Dec 20
Liquidity Ratios
Current Ratio
4.65 3.41 1.83 1.11 1.17
Quick Ratio
3.99 2.97 1.58 0.96 1.01
Cash Ratio
2.76 2.11 1.17 0.28 0.65
Solvency Ratio
1.96 1.25 0.43 -0.66 -0.03
Operating Cash Flow Ratio
1.61 0.73 0.13 -0.90 -0.61
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
£ 25.80M£ 14.80M£ 200.00K£ -7.30M£ -113.70M
Leverage Ratios
Debt-to-Assets Ratio
0.01 0.01 0.02 0.02 0.45
Debt-to-Equity Ratio
0.01 0.01 0.02 0.02 1.31
Debt-to-Capital Ratio
0.01 0.01 0.02 0.02 0.57
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.56
Financial Leverage Ratio
1.09 1.20 1.29 1.56 2.91
Debt Service Coverage Ratio
70.50 190.00 75.00 -175.00 -229.00
Interest Coverage Ratio
23.00 18.00 -43.00 -173.00 -185.00
Debt to Market Cap
0.00 0.00 0.00 0.00 0.02
Interest Debt Per Share
<0.01 <0.01 <0.01 <0.01 0.30
Net Debt to EBITDA
-2.16 -1.19 -3.65 0.64 -6.98
Profitability Margins
Gross Profit Margin
72.01%70.93%68.10%68.20%73.70%
EBIT Margin
11.41%5.75%-7.17%-75.73%-79.48%
EBITDA Margin
23.64%49.20%11.11%-38.08%-34.97%
Operating Profit Margin
12.50%5.75%-15.41%-72.38%-53.47%
Pretax Profit Margin
11.14%33.55%-7.53%-76.99%-79.77%
Net Profit Margin
29.08%51.44%12.90%-140.17%-48.55%
Continuous Operations Profit Margin
25.82%45.05%8.24%-112.13%-48.55%
Net Income Per EBT
260.98%153.33%-171.43%182.07%60.87%
EBT Per EBIT
89.13%583.33%48.84%106.36%149.19%
Return on Assets (ROA)
11.69%16.35%4.17%-32.49%-6.81%
Return on Equity (ROE)
12.77%19.66%5.39%-50.68%-19.81%
Return on Capital Employed (ROCE)
5.46%2.02%-5.69%-22.64%-9.00%
Return on Invested Capital (ROIC)
12.55%2.69%6.20%-32.64%-12.49%
Return on Tangible Assets
18.23%26.22%8.13%-63.57%-21.27%
Earnings Yield
0.04%0.11%0.02%-0.31%-0.24%
Efficiency Ratios
Receivables Turnover
8.98 8.46 10.73 1.48 2.34
Payables Turnover
9.36 18.20 17.80 1.46 1.00
Inventory Turnover
2.15 2.22 3.30 1.90 1.40
Fixed Asset Turnover
26.29 28.45 19.93 17.07 14.42
Asset Turnover
0.40 0.32 0.32 0.23 0.14
Working Capital Turnover Ratio
1.52 2.01 4.65 4.78 -1.09
Cash Conversion Cycle
171.78 187.54 124.24 188.25 51.84
Days of Sales Outstanding
40.67 43.15 34.01 245.88 156.13
Days of Inventory Outstanding
170.10 164.45 110.73 192.11 260.71
Days of Payables Outstanding
38.98 20.05 20.51 249.74 365.00
Operating Cycle
210.76 207.60 144.74 437.98 416.84
Cash Flow Ratios
Operating Cash Flow Per Share
0.03 0.02 <0.01 -0.06 -0.07
Free Cash Flow Per Share
0.03 0.02 <0.01 -0.06 -0.07
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
0.97 0.99 0.86 1.02 1.01
Dividend Paid and CapEx Coverage Ratio
1.07 67.00 7.00 -47.80 -83.67
Capital Expenditure Coverage Ratio
38.67 67.00 7.00 -47.80 -83.67
Operating Cash Flow Coverage Ratio
10.55 6.70 1.08 -14.94 -0.23
Operating Cash Flow to Sales Ratio
0.32 0.21 0.05 -1.00 -0.73
Free Cash Flow Yield
0.04%0.04%<0.01%-0.23%-0.36%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
2.63K 950.36 4.65K -321.45 -422.64
Price-to-Sales (P/S) Ratio
765.05 488.84 600.42 450.56 205.21
Price-to-Book (P/B) Ratio
335.96 186.82 250.77 162.91 83.73
Price-to-Free Cash Flow (P/FCF) Ratio
2.49K 2.32K 13.96K -441.33 -279.54
Price-to-Operating Cash Flow Ratio
2.43K 2.28K 11.97K -450.56 -282.88
Price-to-Earnings Growth (PEG) Ratio
-78.32 2.78 -42.33 -3.39 6.23
Price-to-Fair Value
335.96 186.82 250.77 162.91 83.73
Enterprise Value Multiple
3.23K 992.36 5.40K -1.18K -593.78
Enterprise Value
EV to EBITDA
3.23K 992.36 5.40K -1.18K -593.78
EV to Sales
764.54 488.25 600.02 450.32 207.65
EV to Free Cash Flow
2.49K 2.32K 13.95K -441.09 -282.86
EV to Operating Cash Flow
2.43K 2.28K 11.96K -450.32 -286.25
Tangible Book Value Per Share
0.12 0.11 0.06 0.04 -0.22
Shareholders’ Equity Per Share
0.20 0.20 0.16 0.17 0.23
Tax and Other Ratios
Effective Tax Rate
-1.32 -0.34 2.10 -0.46 -0.39
Revenue Per Share
0.09 0.07 0.07 0.06 0.09
Net Income Per Share
0.03 0.04 <0.01 -0.09 -0.04
Tax Burden
2.61 1.53 -1.71 1.82 0.61
Interest Burden
0.98 5.83 1.05 1.02 1.00
Research & Development to Revenue
0.06 0.10 0.16 0.28 1.48
SG&A to Revenue
0.23 0.24 0.24 0.43 0.36
Stock-Based Compensation to Revenue
0.07 0.03 0.01 0.08 0.04
Income Quality
2.19 0.54 -1.75 0.95 0.52
Currency in GBP
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis